BEKSAÇ, M. Et Al. 2018. A prospective analysis on the frequency and predictive value of minimal residual disease assessment by flow cytometry and PET-CT imaging among myeloma patients on/off maintenance. 23rd Congress of the European Hematology Association, 2021 , 249.

BEKSAÇ, M., CENGİZ SEVAL, G., ŞAHİN, U., MERTER, M., İPEK, Ş., ÖZKAN, E., ... DALVA, K.(2018). A prospective analysis on the frequency and predictive value of minimal residual disease assessment by flow cytometry and PET-CT imaging among myeloma patients on/off maintenance . 23rd Congress of the European Hematology Association, 2021 (pp.249).

BEKSAÇ, MERAL Et Al. "A prospective analysis on the frequency and predictive value of minimal residual disease assessment by flow cytometry and PET-CT imaging among myeloma patients on/off maintenance," 23rd Congress of the European Hematology Association, 2021, 2018

BEKSAÇ, MERAL Et Al. "A prospective analysis on the frequency and predictive value of minimal residual disease assessment by flow cytometry and PET-CT imaging among myeloma patients on/off maintenance." 23rd Congress of the European Hematology Association, 2021 , pp.249, 2018

BEKSAÇ, M. Et Al. (2018) . "A prospective analysis on the frequency and predictive value of minimal residual disease assessment by flow cytometry and PET-CT imaging among myeloma patients on/off maintenance." 23rd Congress of the European Hematology Association, 2021 , p.249.

@conferencepaper{conferencepaper, author={MERAL BEKSAÇ Et Al. }, title={A prospective analysis on the frequency and predictive value of minimal residual disease assessment by flow cytometry and PET-CT imaging among myeloma patients on/off maintenance}, congress name={23rd Congress of the European Hematology Association, 2021}, city={}, country={}, year={2018}, pages={249} }